The objective of this study is to determine if a subject's genetic make-up would affect the
treatment response to codeine in subjects with sickle cell disease.
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Completed
VA Office of Research and Development
Phase 4
2007-10-01
The purpose of this study was to determine whether a low dose an opiate pain medication is
effective for the treatment of discomfort in patients with advanced dementia. The study
medication was also known as Lortab and contained both a narcotic pain medication and
acetaminophen (the same pain medication as contained in Tylenol). This study was an
eight-week long clinical trial for discomfort among veterans with advanced dementia who were
admitted to a Nursing Home Care Unit (NHCU) at the Tuscaloosa VA Medical Center.
The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache
Completed
Albany Medical College
Phase 4
2007-12-01
This study will compare the degree of pain control provided by two techniques for persons
with toothache in an emergency department. The two techniques include;
- standard oral narcotic pain medication
- numbing the tooth with local anesthetic by needle injection
The hypothesis is that celecoxib effectively reduces pain after a tonsillectomy and reduces
post-operative narcotic use.
To test this hypothesis, the study is placebo controlled (sugar pill). Half of the
participants will receive a sugar pill, half will not.
All participants will receive the standard post-operative pain medications.
We ask participants to log the amount of medications they use daily, and the amount of pain
they have each day. It is hoped that celecoxib will reduce the amount of post-operative pain
medication needed.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.